Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2019

Table of Contents

• 1.1 List of Tables 5
• 1.2 List of Figures 9

2 Introduction 10

• 2.1 Bioabsorbable Stents (BAS) Overview 10

3 Products under Development 11

• 3.1 Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development 11
• 3.2 Bioabsorbable Stents (BAS) - Pipeline Products by Territory 12
• 3.3 Bioabsorbable Stents (BAS) - Pipeline Products by Regulatory Path 13
• 3.4 Bioabsorbable Stents (BAS) - Pipeline Products by Estimated Approval Date 14
• 3.5 Bioabsorbable Stents (BAS) - Ongoing Clinical Trials 15

4 Bioabsorbable Stents (BAS) - Pipeline Products under Development by Companies 16

• 4.1 Bioabsorbable Stents (BAS) Companies - Pipeline Products by Stage of Development 16
• 4.2 Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development 18

5 Bioabsorbable Stents (BAS) Companies and Product Overview 20

• 5.1 Abbott Vascular Inc Company Overview 20
  • 5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 20
• 5.2 Amaranth Medical Inc Company Overview 21
  • 5.2.1 Amaranth Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 21
• 5.3 Arterius Ltd Company Overview 30
  • 5.3.1 Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
• 5.4 Biosensors International Group Ltd Company Overview 31
  • 5.4.1 Biosensors International Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 31
• 5.5 Biosten, LLC Company Overview 32
  • 5.5.1 Biosten, LLC Pipeline Products & Ongoing Clinical Trials Overview 32
• 5.6 Biotronik AG Company Overview 33
  • 5.6.1 Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview 33
• 5.7 Biotronik SE & Co KG Company Overview 43
  • 5.7.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 43
• 5.8 Boston Scientific Corp Company Overview 44
  • 5.8.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 44
• 5.9 Cardionovum GmbH Company Overview 49
  • 5.9.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview 49
• 5.10 Cordis Corp Company Overview 50
  • 5.10.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 50
• 5.11 HangZhou HuaAn Biotechnology Co., Ltd. Company Overview 51
  • 5.11.1 HangZhou HuaAn Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 51
• 5.12 Icon Interventional Systems, Inc. Company Overview 52
  • 5.12.1 Icon Interventional Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
• 5.13 Japan Stent Technology Co., Ltd. Company Overview 53
  • 5.13.1 Japan Stent Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 53
• 5.14 Kyoto Medical Planning Co Ltd Company Overview 54
  • 5.14.1 Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 54
• 5.15 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 55
  • 5.15.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
• 5.16 Manli Cardiology Ltd Company Overview 58
  • 5.16.1 Manli Cardiology Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
• 5.17 Micell Technologies Inc Company Overview 59
  • 5.17.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 59
• 5.18 Michigan Technological University Company Overview 64
  • 5.18.1 Michigan Technological University Pipeline Products & Ongoing Clinical Trials Overview 64
• 5.19 MicroPort Scientific Corp Company Overview 65
  • 5.19.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 65
• 5.20 Minvasys SAS Company Overview 69
  • 5.20.1 Minvasys SAS Pipeline Products & Ongoing Clinical Trials Overview 69
• 5.21 MIV Therapeutics Inc Company Overview 70
  • 5.21.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 70
• 5.22 NanoCoeur, Inc. Company Overview 72
  • 5.22.1 NanoCoeur, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
• 5.23 North Carolina State University Company Overview 73
  • 5.23.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 73
• 5.24 Northwestern University Company Overview 74
  • 5.24.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 74
• 5.25 OrbusNeich Company Overview 75
  • 5.25.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 75
• 5.26 Pediastent LLC Company Overview 77
  • 5.26.1 Pediastent LLC Pipeline Products & Ongoing Clinical Trials Overview 77
• 5.27 QualiMed Innovative Medizinprodukte GmbH Company Overview 78
  • 5.27.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 78
• 5.28 REVA Medical Inc Company Overview 79
  • 5.28.1 REVA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 79
• 5.29 S3V Vascular Technologies Company Overview 84
  • 5.29.1 S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview 84
• 5.30 Tepha Inc Company Overview 85
  • 5.30.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 85
• 5.31 University of Alabama at Birmingham Company Overview 86
  • 5.31.1 University of Alabama at Birmingham Pipeline Products & Ongoing Clinical Trials Overview 86
• 5.32 University of Florida Company Overview 87
  • 5.32.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 87
• 5.33 University of Strathclyde Company Overview 88
  • 5.33.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 88
• 5.34 VasoTech Inc. Company Overview 89
  • 5.34.1 VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview 89
• 5.35 Xenogenics Corporation Company Overview 90
  • 5.35.1 Xenogenics Corporation Pipeline Products & Ongoing Clinical Trials Overview 90

6 Bioabsorbable Stents (BAS)- Recent Developments 93

• 6.1 Nov 06, 2019: Final five unpublished late-breaking clinical trial results announced at VIVA19 93
• 6.2 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 95
• 6.3 Sep 20, 2019: Terumo to increase production capacity for alliance business 97
• 6.4 Aug 29, 2019: MicroPort announces interim results for the six months ended June 30, 2019 98
• 6.5 Aug 28, 2019: Boston Scientific Celebrates 15th Anniversary in Costa Rica 100

7 Appendix 116

• 7.1 Methodology 116
• 7.2 About GlobalData 119
• 7.3 Contact Us 119